Platelet-Rich Plasma Market
Platelet-Rich Plasma Market Analysis By Product Type (Platelet-Rich Plasma Instruments, Pure Platelet-Rich Plasma Kits, Platelet-Rich Fibrin Kits, Pure Platelet-Rich Fibrin Kits), By Application (Orthopedic Surgery, Cosmetic Surgery, General Surgery), By End Use & Region - Global Market Insights 2021 to 2031
Analysis of Platelet-Rich Plasma Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Platelet-Rich Plasma Market Outlook (2021 to 2031)
The platelet-rich plasma market is slated to touch an impressive valuation of around US$ 1.5 Billion surpassing a CAGR of 12% during the assessment period.
The market remains influenced by its integral use in the healthcare industry, especially in orthopedic surgeries and cosmetic surgeries. Injuries like the rotator cuff, tendon injuries, tennis elbow, and hamstring among others are healed quickly and effectively with the help of platelet-rich plasma therapy.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Consumption Analysis of Platelet-Rich Plasma from 2016 to 2020 Vs Market Outlook for 2021 to 2031
As per Fact.MR – a market research and competitive intelligence provider- over the last 5 years, the global market for platelet-rich plasma expanded at over 10% CAGR, closing in at over US$ 400 Million. Increasing sports injuries incidence have majorly heightened demand in recent years.
Application prospects further widened during the COVID-19 pandemic. Studies advocating possible inoculation against the novel coronavirus after administering the plasma of a formerly infected patient has elevated its prospects manifold.
Fact.MR projects demand for platelet-rich plasma to surpass a value of US$ 1.5 Billion by 2031, registering a CAGR of over 12%. Treatment of medical conditions such as erectile dysfunction and facelift surgeries are some of new application areas in the platelet-rich plasma market.
How are Hair and Skin Care Therapies Translating into Incremental Opportunities for Stakeholders?
Due to the several application areas where plasma therapy can be used, especially in cosmetic surgeries, the growth of the market for platelet-rich plasma has remained significant.
Apart from musculoskeletal conditions, companies in the platelet-rich plasma market are tapping growth opportunities in hair and skin care. Micro-needling, with the help of platelet-rich plasma injections, holds promising potentials to improve skin texture and appearance.
Platelet-rich plasma is injected deep into the scalp to reach the bottom of the hair follicle. This helps to stimulate a specialized population of cells named dermal papilla cells, which contribute to hair growth. Companies in the platelet-rich plasma market are increasing their production of injections that aid in hair growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Why is Increasing Prevalence of AGA Stimulating PRP Therapy Uptake?
According to National Center for Biotechnology Information, in addition to its original intended use for skin rejuvenation, micro-needling is gaining traction for novel uses such as transcutaneous medication delivery.
The high prevalence of androgenetic alopecia (AGA), i.e. hormone-related baldness in individuals worldwide is acting as a key driver for the market. This form of hair loss affects an estimated 50 million men and 30 million women in the United States. Androgenetic alopecia can start as early as a person's teens and the risk increases with age; more than 50 percent of men over age 50 have some degree of hair loss.
Is Platelet-Rich Plasma Therapy an Alternative to Steroid-based Therapy?
Platelet-rich plasma is trending as a quick and effective treatment for orthopedic diseases, neurological diseases, sports injuries, and cardiothoracic diseases. Companies in the platelet-rich plasma market are becoming aware of the benefits of platelet-rich plasma therapy for back pain.
Interventional pain physicians at the Ohio State University Wexner Medical Center are utilizing platelet-rich plasma (PRP) injections to treat sacroiliac (SI) joint pain and back pain. The treatment has been widely studied and used for knee osteoarthritis and physicians are not using the therapy to treat other joints, particularly in the spine.
Platelet-rich plasma therapy is emerging as an alternative to steroid injections and is contributing towards the growth of the platelet-rich plasma market owing to its long-lasting benefits as compared to steroids.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-Wise Analysis
How is the U.S Emerging as a Promising Hub for Platelet-Rich Plasma Therapy?
The United States is anticipated to dominate the market demand for platelet-rich plasma during the forecast period, experiencing a CAGR of around 9% until 2031.
The U.S Food and Drug Administration oversaw multiple clinical trials regarding the potential of plasma-rich proteins in treating COVID-19, prompting healthcare providers and leading manufacturers to increase PRP therapy uptake.
As per a survey conducted by the Centers for Disease Control and Prevention (CDC), in the United States, about 54.4 million adults (22.7%) are diagnosed with common arthritis, rheumatoid arthritis, and gout, increasing uptake of the treatment.
According to research, around 86,000 athletes are treated with plasma-rich protein therapy in the U.S. annually. Moreover, platelets play an important role in healing wounds and other muscular injuries. This is anticipated to drive the segment over the next few years.
What is the Demand Outlook for Platelet-Rich Plasma in the U.K?
The U.K is projected to be the most lucrative market for platelet-rich plasma across Europe, with growth bolstering owing to the increasing number of sports injuries.
As per Fact.MR projections, the market is projected to expand through 2031 registering nearly 8% CAGR.
What are the Growth Opportunities for Platelet-Rich Plasma in India?
India is expected to showcase impressive growth prospects for the market for platelet-rich plasma during the forecast period. Uptake is increasing due to high prevalence of inflammatory disorders.
According to Arthritis India, arthritis affects 15% of people, i.e., over 210 million people in India. Dearth of trained rheumatologists in India has led to the management of these diseases by untrained doctors, alternative medicine practitioners, and quacks. Arthritis-India aims at providing scientific information on arthritis and allied conditions and helps patients overcome their problems.
Considering these factors, the Indian region is projected to capture a major market share in the overall Asia-pacific region. A CAGR of approximately 8% has been projected for the Indian market.
Category-Wise Analysis
Why are Hospitals the Primary Point-of-Care Centers for PRP Therapy?
Hospitals are increasingly witnessing an inflow of patients opting for PRP injections to treat orthopedic conditions. Moreover, the doctors treat osteoarthritis with platelet-rich plasma by injecting it directly into the affected joint to reduce pain, improve joint function, and slow, halt, or even repair damage to the cartilage.
As per the forecast of Fact.MR, the hospitals end-user segment is slated to register a 10% CAGR during the forecast period.
Why are Pure Platelet-Rich Plasma Kits Surging in Demand?
The pure platelet-rich plasma kits segments dominated the global market in 2020, comprising over 50% of global revenue. Multiple advantages, including faster healing process, tissue repair and generation and improvement in overall function have heightened its demand.
Effective elimination of risks and adverse effects, such as an allergic or immune reaction in pure PRP therapeutic approach, has gained the attention of entities operating in the market.
Competitive Landscape
The market is moderately competitive and is divided into companies that are expected to remain active in the expansion of the global platelet-rich plasma market through 2031.
Players focus on adopting various strategies to expand product offerings and strengthen geographic presence. With the advancement in technology, new players are expected to enter the market.
- In February 2021, Atlas Health Medical Group announced PRP availability (Platelet Rich Plasma) Microneedling Facelifts to patients. In addition to this, in February 2020, EmCyte completed the acquisition of Cellmedix Holdings LLC, including all the assets of the U.S.-based company such as the proprietary product system, namely Centrepid Platelet Concentrator.
Report Scope
| Report Attributes | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Key Market Segments Covered | Product Type, End User, Application, Region |
| Key Companies Profiled | Arthrex, Inc.; Johnson & Johnson; Zimmer Biomet Holdings, Inc.; Exactech, Inc.; Stryker Corporation; Terumo Medical Corporation; Biotest Aktiengesellschaft; CSL Ltd |
Key Segments Covered
-
By Product Type:
- Platelet-Rich Plasma Instruments
- Pure Platelet-Rich Plasma Kits
- Leucocyte-Rich Platelet-Rich Plasma Kits
- Platelet-Rich Fibrin Kits
- Pure Platelet-Rich Fibrin Kits
-
By Application:
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Neurosurgery
- Other Surgeries
-
By End User:
- Hospitals
- Orthopedic Clinics
- Dermatology Clinics
- by Other End Users
-
By Regions:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By Product Type
- 3.1. Instruments
- 3.2. Pure
- 3.3. Leukocyte-Rich
- 3.4. Leukocyte
- 3.5. Pure
- 4. Global Market Analysis and Forecast By End User
- 4.1. Hospitals
- 4.2. Orthopedic Clinics
- 4.3. Dermatology Clinics
- 4.4. Others Platelet-Rich
- 5. Global Market Analysis and Forecast By Application
- 5.1. Orthopedic Surgery
- 5.2. Cosmetic Surgery
- 5.3. General Surgery
- 5.4. Neurosurgery
- 5.5. Other Surgeries
- 6. Global Market Analysis and Forecast By Region
- 6.1. North America
- 6.2. Latin America
- 6.3. Europe
- 6.4. Japan
- 6.5. APEJ
- 6.6. MEA
- 7. North America Market Analysis and Forecast, By Country, 2016 to 2031
- 8. Latin America Market Analysis and Forecast, By Country, 2016 to 2031
- 9. Europe Market Analysis and Forecast, By Country, 2016 to 2031
- 10. Japan Market Analysis and Forecast, By Country, 2016 to 2031
- 11. APEJ Market Analysis and Forecast, By Country, 2016 to 2031
- 12. MEA Market Analysis and Forecast, By Country, 2016 to 2031
- 13. Global Market Competition Landscape and Company Profile
- 13.1. Arthrex, Inc
- 13.2. Johnson & Johnson
- 13.3. Zimmer Biomet Holdings, Inc
- 13.4. Exactech, Inc
- 13.5. Stryker Corporation
- 13.6. Terumo Medical Corporation
- 13.7. Biotest Aktiengesellschaft
- 13.8. CSL Limited
- 14. Research Methodology
- 15. Secondary and Primary Sources
- 16. Assumptions and Acronyms
- 17. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2016 to 2020
TABLE 02: Global Market Value (US$ Mn), 2021 to 2031
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2020 to 2031
TABLE 04: Global Instruments Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 05: Global Instruments Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 06: Global Instruments Segment Market Share, By Region 2016 to 2020
TABLE 07: Global Instruments Segment Market Share, By Region 2021 to 2031
TABLE 08: Global Instruments Segment Y-o-Y, By Region 2020 to 2031
TABLE 09: Global Pure Kits Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 10: Global Pure Kits Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 11: Global Pure Kits Segment Market Share, By Region 2016 to 2020
TABLE 12: Global Pure Kits Segment Market Share, By Region 2021 to 2031
TABLE 13: Global Pure Kits Segment Y-o-Y, By Region 2020 to 2031
TABLE 14: Global Leukocyte-Rich Kits Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 15: Global Leukocyte-Rich Kits Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 16: Global Leukocyte-Rich Kits Segment Market Share, By Region 2016 to 2020
TABLE 17: Global Leukocyte-Rich Kits Segment Market Share, By Region 2021 to 2031
TABLE 18: Global Leukocyte-Rich Kits Segment Y-o-Y, By Region 2020 to 2031
TABLE 19: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 20: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 21: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Market Share, By Region 2016 to 2020
TABLE 22: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Market Share, By Region 2021 to 2031
TABLE 23: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Y-o-Y, By Region 2020 to 2031
TABLE 24: Global Pure Platelet-Rich Fibrin Kits Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 25: Global Pure Platelet-Rich Fibrin Kits Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 26: Global Pure Platelet-Rich Fibrin Kits Segment Market Share, By Region 2016 to 2020
TABLE 27: Global Pure Platelet-Rich Fibrin Kits Segment Market Share, By Region 2021 to 2031
TABLE 28: Global Pure Platelet-Rich Fibrin Kits Segment Y-o-Y, By Region 2020 to 2031
TABLE 29: Global Hospitals Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 30: Global Hospitals Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 31: Global Hospitals Segment Market Share, By Region 2016 to 2020
TABLE 32: Global Hospitals Segment Market Share, By Region 2021 to 2031
TABLE 33: Global Hospitals Segment Y-o-Y, By Region 2020 to 2031
TABLE 34: Global Orthopedic Clinics Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 35: Global Orthopedic Clinics Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 36: Global Orthopedic Clinics Segment Market Share, By Region 2016 to 2020
TABLE 37: Global Orthopedic Clinics Segment Market Share, By Region 2021 to 2031
TABLE 38: Global Orthopedic Clinics Segment Y-o-Y, By Region 2020 to 2031
TABLE 39: Global Dermatology Clinics Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 40: Global Dermatology Clinics Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 41: Global Dermatology Clinics Segment Market Share, By Region 2016 to 2020
TABLE 42: Global Dermatology Clinics Segment Market Share, By Region 2021 to 2031
TABLE 43: Global Dermatology Clinics Segment Y-o-Y, By Region 2020 to 2031
TABLE 44: Global Others Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 45: Global Others Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 46: Global Others Segment Market Share, By Region 2016 to 2020
TABLE 47: Global Others Segment Market Share, By Region 2021 to 2031
TABLE 48: Global Others Segment Y-o-Y, By Region 2020 to 2031
TABLE 49: Global Orthopedic Surgery Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 50: Global Orthopedic Surgery Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 51: Global Orthopedic Surgery Segment Market Share, By Region 2016 to 2020
TABLE 52: Global Orthopedic Surgery Segment Market Share, By Region 2021 to 2031
TABLE 53: Global Orthopedic Surgery Segment Y-o-Y, By Region 2020 to 2031
TABLE 54: Global Cosmetic Surgery Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 55: Global Cosmetic Surgery Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 56: Global Cosmetic Surgery Segment Market Share, By Region 2016 to 2020
TABLE 57: Global Cosmetic Surgery Segment Market Share, By Region 2021 to 2031
TABLE 58: Global Cosmetic Surgery Segment Y-o-Y, By Region 2020 to 2031
TABLE 59: Global General Surgery Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 60: Global General Surgery Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 61: Global General Surgery Segment Market Share, By Region 2016 to 2020
TABLE 62: Global General Surgery Segment Market Share, By Region 2021 to 2031
TABLE 63: Global General Surgery Segment Y-o-Y, By Region 2020 to 2031
TABLE 64: Global Neurosurgery Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 65: Global Neurosurgery Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 66: Global Neurosurgery Segment Market Share, By Region 2016 to 2020
TABLE 67: Global Neurosurgery Segment Market Share, By Region 2021 to 2031
TABLE 68: Global Neurosurgery Segment Y-o-Y, By Region 2020 to 2031
TABLE 69: Global Other Surgeries Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 70: Global Other Surgeries Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 71: Global Other Surgeries Segment Market Share, By Region 2016 to 2020
TABLE 72: Global Other Surgeries Segment Market Share, By Region 2021 to 2031
TABLE 73: Global Other Surgeries Segment Y-o-Y, By Region 2020 to 2031
TABLE 74: North America Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 75: North America Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 76: North America Market Value (US$ Mn), By End User 2016 to 2020
TABLE 77: North America Market Value (US$ Mn), By End User 2021 to 2031
TABLE 78: North America Market Value (US$ Mn), By Application 2016 to 2020
TABLE 79: North America Market Value (US$ Mn), By Application 2021 to 2031
TABLE 80: Latin America Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 81: Latin America Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 82: Latin America Market Value (US$ Mn), By End User 2016 to 2020
TABLE 83: Latin America Market Value (US$ Mn), By End User 2021 to 2031
TABLE 84: Latin America Market Value (US$ Mn), By Application 2016 to 2020
TABLE 85: Latin America Market Value (US$ Mn), By Application 2021 to 2031
TABLE 86: Europe Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 87: Europe Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 88: Europe Market Value (US$ Mn), By End User 2016 to 2020
TABLE 89: Europe Market Value (US$ Mn), By End User 2021 to 2031
TABLE 90: Europe Market Value (US$ Mn), By Application 2016 to 2020
TABLE 91: Europe Market Value (US$ Mn), By Application 2021 to 2031
TABLE 92: Japan Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 93: Japan Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 94: Japan Market Value (US$ Mn), By End User 2016 to 2020
TABLE 95: Japan Market Value (US$ Mn), By End User 2021 to 2031
TABLE 96: Japan Market Value (US$ Mn), By Application 2016 to 2020
TABLE 97: Japan Market Value (US$ Mn), By Application 2021 to 2031
TABLE 98: APEJ Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 99: APEJ Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 100: APEJ Market Value (US$ Mn), By End User 2016 to 2020
TABLE 101: APEJ Market Value (US$ Mn), By End User 2021 to 2031
TABLE 102: APEJ Market Value (US$ Mn), By Application 2016 to 2020
TABLE 103: APEJ Market Value (US$ Mn), By Application 2021 to 2031
TABLE 104: MEA Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 105: MEA Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 106: MEA Market Value (US$ Mn), By End User 2016 to 2020
TABLE 107: MEA Market Value (US$ Mn), By End User 2021 to 2031
TABLE 108: MEA Market Value (US$ Mn), By Application 2016 to 2020
TABLE 109: MEA Market Value (US$ Mn), By Application 2021 to 2031
TABLE 110: US Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 111: US Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 112: US Market Value (US$ Mn), By End User 2016 to 2020
TABLE 113: US Market Value (US$ Mn), By End User 2021 to 2031
TABLE 114: US Market Value (US$ Mn), By Application 2016 to 2020
TABLE 115: US Market Value (US$ Mn), By Application 2021 to 2031
TABLE 116: Canada Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 117: Canada Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 118: Canada Market Value (US$ Mn), By End User 2016 to 2020
TABLE 119: Canada Market Value (US$ Mn), By End User 2021 to 2031
TABLE 120: Canada Market Value (US$ Mn), By Application 2016 to 2020
TABLE 121: Canada Market Value (US$ Mn), By Application 2021 to 2031
TABLE 122: Brazil Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 123: Brazil Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 124: Brazil Market Value (US$ Mn), By End User 2016 to 2020
TABLE 125: Brazil Market Value (US$ Mn), By End User 2021 to 2031
TABLE 126: Brazil Market Value (US$ Mn), By Application 2016 to 2020
TABLE 127: Brazil Market Value (US$ Mn), By Application 2021 to 2031
TABLE 128: Mexico Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 129: Mexico Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 130: Mexico Market Value (US$ Mn), By End User 2016 to 2020
TABLE 131: Mexico Market Value (US$ Mn), By End User 2021 to 2031
TABLE 132: Mexico Market Value (US$ Mn), By Application 2016 to 2020
TABLE 133: Mexico Market Value (US$ Mn), By Application 2021 to 2031
TABLE 134: Argentina Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 135: Argentina Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 136: Argentina Market Value (US$ Mn), By End User 2016 to 2020
TABLE 137: Argentina Market Value (US$ Mn), By End User 2021 to 2031
TABLE 138: Argentina Market Value (US$ Mn), By Application 2016 to 2020
TABLE 139: Argentina Market Value (US$ Mn), By Application 2021 to 2031
TABLE 140: Germany Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 141: Germany Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 142: Germany Market Value (US$ Mn), By End User 2016 to 2020
TABLE 143: Germany Market Value (US$ Mn), By End User 2021 to 2031
TABLE 144: Germany Market Value (US$ Mn), By Application 2016 to 2020
TABLE 145: Germany Market Value (US$ Mn), By Application 2021 to 2031
TABLE 146: UK Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 147: UK Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 148: UK Market Value (US$ Mn), By End User 2016 to 2020
TABLE 149: UK Market Value (US$ Mn), By End User 2021 to 2031
TABLE 150: UK Market Value (US$ Mn), By Application 2016 to 2020
TABLE 151: UK Market Value (US$ Mn), By Application 2021 to 2031
TABLE 152: France Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 153: France Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 154: France Market Value (US$ Mn), By End User 2016 to 2020
TABLE 155: France Market Value (US$ Mn), By End User 2021 to 2031
TABLE 156: France Market Value (US$ Mn), By Application 2016 to 2020
TABLE 157: France Market Value (US$ Mn), By Application 2021 to 2031
TABLE 158: Spain Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 159: Spain Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 160: Spain Market Value (US$ Mn), By End User 2016 to 2020
TABLE 161: Spain Market Value (US$ Mn), By End User 2021 to 2031
TABLE 162: Spain Market Value (US$ Mn), By Application 2016 to 2020
TABLE 163: Spain Market Value (US$ Mn), By Application 2021 to 2031
TABLE 164: Italy Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 165: Italy Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 166: Italy Market Value (US$ Mn), By End User 2016 to 2020
TABLE 167: Italy Market Value (US$ Mn), By End User 2021 to 2031
TABLE 168: Italy Market Value (US$ Mn), By Application 2016 to 2020
TABLE 169: Italy Market Value (US$ Mn), By Application 2021 to 2031
TABLE 170: Nordic Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 171: Nordic Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 172: Nordic Market Value (US$ Mn), By End User 2016 to 2020
TABLE 173: Nordic Market Value (US$ Mn), By End User 2021 to 2031
TABLE 174: Nordic Market Value (US$ Mn), By Application 2016 to 2020
TABLE 175: Nordic Market Value (US$ Mn), By Application 2021 to 2031
TABLE 176: Japan Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 177: Japan Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 178: Japan Market Value (US$ Mn), By End User 2016 to 2020
TABLE 179: Japan Market Value (US$ Mn), By End User 2021 to 2031
TABLE 180: Japan Market Value (US$ Mn), By Application 2016 to 2020
TABLE 181: Japan Market Value (US$ Mn), By Application 2021 to 2031
TABLE 182: China Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 183: China Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 184: China Market Value (US$ Mn), By End User 2016 to 2020
TABLE 185: China Market Value (US$ Mn), By End User 2021 to 2031
TABLE 186: China Market Value (US$ Mn), By Application 2016 to 2020
TABLE 187: China Market Value (US$ Mn), By Application 2021 to 2031
TABLE 188: India Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 189: India Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 190: India Market Value (US$ Mn), By End User 2016 to 2020
TABLE 191: India Market Value (US$ Mn), By End User 2021 to 2031
TABLE 192: India Market Value (US$ Mn), By Application 2016 to 2020
TABLE 193: India Market Value (US$ Mn), By Application 2021 to 2031
TABLE 194: Malaysia Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 195: Malaysia Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 196: Malaysia Market Value (US$ Mn), By End User 2016 to 2020
TABLE 197: Malaysia Market Value (US$ Mn), By End User 2021 to 2031
TABLE 198: Malaysia Market Value (US$ Mn), By Application 2016 to 2020
TABLE 199: Malaysia Market Value (US$ Mn), By Application 2021 to 2031
TABLE 200: Thailand Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 201: Thailand Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 202: Thailand Market Value (US$ Mn), By End User 2016 to 2020
TABLE 203: Thailand Market Value (US$ Mn), By End User 2021 to 2031
TABLE 204: Thailand Market Value (US$ Mn), By Application 2016 to 2020
TABLE 205: Thailand Market Value (US$ Mn), By Application 2021 to 2031
TABLE 206: Singapore Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 207: Singapore Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 208: Singapore Market Value (US$ Mn), By End User 2016 to 2020
TABLE 209: Singapore Market Value (US$ Mn), By End User 2021 to 2031
TABLE 210: Singapore Market Value (US$ Mn), By Application 2016 to 2020
TABLE 211: Singapore Market Value (US$ Mn), By Application 2021 to 2031
TABLE 212: Australia Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 213: Australia Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 214: Australia Market Value (US$ Mn), By End User 2016 to 2020
TABLE 215: Australia Market Value (US$ Mn), By End User 2021 to 2031
TABLE 216: Australia Market Value (US$ Mn), By Application 2016 to 2020
TABLE 217: Australia Market Value (US$ Mn), By Application 2021 to 2031
TABLE 218: GCC Countries Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 219: GCC Countries Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 220: GCC Countries Market Value (US$ Mn), By End User 2016 to 2020
TABLE 221: GCC Countries Market Value (US$ Mn), By End User 2021 to 2031
TABLE 222: GCC Countries Market Value (US$ Mn), By Application 2016 to 2020
TABLE 223: GCC Countries Market Value (US$ Mn), By Application 2021 to 2031
TABLE 224: South Africa Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 225: South Africa Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 226: South Africa Market Value (US$ Mn), By End User 2016 to 2020
TABLE 227: South Africa Market Value (US$ Mn), By End User 2021 to 2031
TABLE 228: South Africa Market Value (US$ Mn), By Application 2016 to 2020
TABLE 229: South Africa Market Value (US$ Mn), By Application 2021 to 2031
TABLE 230: Nigeria Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 231: Nigeria Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 232: Nigeria Market Value (US$ Mn), By End User 2016 to 2020
TABLE 233: Nigeria Market Value (US$ Mn), By End User 2021 to 2031
TABLE 234: Nigeria Market Value (US$ Mn), By Application 2016 to 2020
TABLE 235: Nigeria Market Value (US$ Mn), By Application 2021 to 2031
TABLE 236: Israel Market Value (US$ Mn), By Product Type 2016 to 2020
TABLE 237: Israel Market Value (US$ Mn), By Product Type 2021 to 2031
TABLE 238: Israel Market Value (US$ Mn), By End User 2016 to 2020
TABLE 239: Israel Market Value (US$ Mn), By End User 2021 to 2031
TABLE 240: Israel Market Value (US$ Mn), By Application 2016 to 2020
TABLE 241: Israel Market Value (US$ Mn), By Application 2021 to 2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2016 to 2020
FIG. 02: Global Market Value (US$ Mn) Forecast, 2021 to 2031
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2020 to 2031
FIG. 04: Global Instruments Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 05: Global Instruments Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 06: Global Instruments Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 07: Global Pure Kits Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 08: Global Pure Kits Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 09: Global Pure Kits Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 10: Global Leukocyte-Rich Kits Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 11: Global Leukocyte-Rich Kits Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 12: Global Leukocyte-Rich Kits Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 13: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 14: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 15: Global Leukocyte-Platelet-Rich Fibrin Kits Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 16: Global Pure Platelet-Rich Fibrin Kits Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 17: Global Pure Platelet-Rich Fibrin Kits Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 18: Global Pure Platelet-Rich Fibrin Kits Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 19: Global Hospitals Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 20: Global Hospitals Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 21: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 22: Global Orthopedic Clinics Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 23: Global Orthopedic Clinics Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 24: Global Orthopedic Clinics Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 25: Global Dermatology Clinics Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 26: Global Dermatology Clinics Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 27: Global Dermatology Clinics Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 28: Global Others Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 29: Global Others Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 30: Global Others Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 31: Global Orthopedic Surgery Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 32: Global Orthopedic Surgery Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 33: Global Orthopedic Surgery Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 34: Global Cosmetic Surgery Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 35: Global Cosmetic Surgery Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 36: Global Cosmetic Surgery Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 37: Global General Surgery Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 38: Global General Surgery Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 39: Global General Surgery Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 40: Global Neurosurgery Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 41: Global Neurosurgery Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 42: Global Neurosurgery Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 43: Global Other Surgeries Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 44: Global Other Surgeries Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 45: Global Other Surgeries Segment Y-o-Y Growth Rate, By Region, 2020 to 2031
FIG. 46: North America Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 47: North America Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 48: North America Market Value (US$ Mn), By End User 2016 to 2020
FIG. 49: North America Market Value (US$ Mn), By End User 2021 to 2031
FIG. 50: North America Market Value (US$ Mn), By Application 2016 to 2020
FIG. 51: North America Market Value (US$ Mn), By Application 2021 to 2031
FIG. 52: Latin America Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 53: Latin America Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 54: Latin America Market Value (US$ Mn), By End User 2016 to 2020
FIG. 55: Latin America Market Value (US$ Mn), By End User 2021 to 2031
FIG. 56: Latin America Market Value (US$ Mn), By Application 2016 to 2020
FIG. 57: Latin America Market Value (US$ Mn), By Application 2021 to 2031
FIG. 58: Europe Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 59: Europe Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 60: Europe Market Value (US$ Mn), By End User 2016 to 2020
FIG. 61: Europe Market Value (US$ Mn), By End User 2021 to 2031
FIG. 62: Europe Market Value (US$ Mn), By Application 2016 to 2020
FIG. 63: Europe Market Value (US$ Mn), By Application 2021 to 2031
FIG. 64: Japan Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 65: Japan Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 66: Japan Market Value (US$ Mn), By End User 2016 to 2020
FIG. 67: Japan Market Value (US$ Mn), By End User 2021 to 2031
FIG. 68: Japan Market Value (US$ Mn), By Application 2016 to 2020
FIG. 69: Japan Market Value (US$ Mn), By Application 2021 to 2031
FIG. 70: APEJ Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 71: APEJ Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 72: APEJ Market Value (US$ Mn), By End User 2016 to 2020
FIG. 73: APEJ Market Value (US$ Mn), By End User 2021 to 2031
FIG. 74: APEJ Market Value (US$ Mn), By Application 2016 to 2020
FIG. 75: APEJ Market Value (US$ Mn), By Application 2021 to 2031
FIG. 76: MEA Market Value (US$ Mn), By Product Type 2016 to 2020
FIG. 77: MEA Market Value (US$ Mn), By Product Type 2021 to 2031
FIG. 78: MEA Market Value (US$ Mn), By End User 2016 to 2020
FIG. 79: MEA Market Value (US$ Mn), By End User 2021 to 2031
FIG. 80: MEA Market Value (US$ Mn), By Application 2016 to 2020
FIG. 81: MEA Market Value (US$ Mn), By Application 2021 to 2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the platelet-rich plasma market worth?
As of 2020, demand for platelet-rich plasma therapy surpassed US$ 400 Mn in value
What was the last 5 years CAGR for platelet-rich plasma therapy?
Between 2016 and 2020, demand for platelet-rich plasma therapy expanded at around 10% CAGR
What is the anticipated future forecast for platelet-rich plasma demand?
According to Fact.MR, platelet-rich plasma uptake is poised to surge at a staggering 12% CAGR to surpass US$ 1.5 Bn by 2031
What is driving uptake of platelet-rich plasma therapy in recent years?
Increasing scope for treating androgenetic alopecia (AGA) and inflammation disorders such as arthritis are spurring uptake of PRP therapies across major regions
What are the prospects for the U.S platelet-rich plasma landscape?
Uptake of platelet-rich plasma therapy in the U.S is expected to grow at around 9% CAGR
How does the U.K landscape for platelet-rich plasma appear until 2031?
U.K is poised to register nearly 8% CAGR across the 2021-2031 forecast period
What is the scope for India in the global platelet-rich plasma industry?
India is anticipated to account for approximately 8% CAGR with respect to platelet-rich plasma therapy demand
Which is the most prominent platelet-rich plasma therapy type?
Pure platelet-rich plasma therapy is expected to account for over 50% revenue through 2031
Who is the primary end user of platelet-rich plasma?
Hospitals are the primary end users of platelet-rich plasma, growing at 10% CAGR
Which are some prominent platelet-rich plasma manufacturers?
Arthrex Inc., Zimmer Bioment Holdings and Johnson & Johnson are some prominent platelet-rich plasma manufacturers
Platelet-Rich Plasma Market